Neuroprivacy and 2) New Research of the Nervous System Part 1) Due to recent advancements in our ability to measure the electrical activity of the brain, "neuroprivacy" has become an ethical buzzword for neuroscientists. What is neuroprivacy? How close are we to really knowing what another person is thinking? How much should the government regulate the research that might lead to neuroprivacy concerns? Given that medical personnel will remove articles of clothing from the outside of a person without regard for privacy in a medical emergency, how should neuroprivacy be handled in a medical emergency? Should commercial companies have access to your neural records for marketing purposes, or probation officers or judges in court have access for determination of flight risk or criminal intent, or insurance companies have access for determining your probability for engaging in risky behaviors? Is this different or should it be different than when insurance companies charge different rates based on the weight of an individual? Be sure to answer these questions in one initial post and then comment on at least two other posts. http://www.abcny.org/pdf/report/Neuroprivacy-revisions.pdf http://liblogs.albany.edu/UNL_206/2008/04/neuroprivacy.html http://mindhacks.com/2006/06/27/brain-based-lie-detection-now-commercially-available/ 300 words or more – max 400. ———————————————————————————————— Part 2 New Research of the Nervous System Go out on the web and find out about the newest most interesting research being done on the nervous system. Write a brief description of that research that includes: What questions are being asked? What methods are being used? Are there any applications to humans? Are there any ethical/moral/legal dilemmas involved in the research? Be sure to post an initial answer to these questions and comment on two other posts. 200 words .
June 21, 2017
Assignment 3: Environmental Issues and the Industrial Revolution
June 21, 2017

In a double blind experiment, long term pain care patients

In a double blind experiment, long term pain care patients
In a double blind experiment, long term pain care patients were randomly assigned to either take Embeda (Morphine sulfate and Naltrexone hydrochloride) or Kadian
(Morphine sulfate) for a 6 week period, participants were given an appropriate starting dosage of the medication based on their previous therapy dosing determined by
their respective physician. Of 24 people given Embeda, 14 were able to manage their pain with the starting dosage at the end of the 6 week, whereas in the Kadian
group, only 4 of 24 were able to manage their pain with the starting dosage at the end of the 6 week period. Whether a patient maintains the same dose throughout the 6
week period is of particular importance to researchers, as it suggests the medication is stable/effective for pain management.
6. Organize these data/results (i.e. frequencies) into a two-way table.
EmbedaKadian Total
Participants stayed on same dosage
participant dosage increased
Total
Compute the proportion of the overall sample (all 48 participants) that maintained the same medication dosage.
Of the 24 participants assigned to Embeda, what proportion maintained the same medication dosage? Use correct notation.
Of the 24 participants assigned to the Kadian, what proportion maintained the same medication dosage? Use correct notation.
Calculate the sample difference in proportions. Use correct notation.
Interpret the sample difference in proportions in the context of the study.
Calculate the sample relative risk of maintaining the same medication dosage for the Embeda group compared to the Kadian group.
Interpret the sample relative risk in the context of the study.

 

"Are you looking for this answer? We can Help click Order Now"

assignment help